December 17, 2020
Webinar
As part of the Strafford Publications’ webinar series, Finnegan attorneys Mark Feldstein, Cora Holt, Tom Irving, and Kyu Kim will join a panel discussion on the Federal Circuit’s recent GSK v. Teva decision, and other relevant post-launch non-Hatch Waxman pharmaceutical litigations. The panel will also discuss strategies regarding claim language and label language, as well as types of evidence to adduce to prove inducement of infringement. For more information, or to register, please see Strafford’s website.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Hybrid Seminar
Pandora’s Pixels: Can Privacy and Choice Survive in our Generative AI World?
April 11, 2024
Richmond
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Virtual Seminar
Prosecuting and Challenging Patent Applications/Careers in IP Law: A World of Possibilities
February 28, 2024
Virtual
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.